4.5 Article

Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation

Related references

Note: Only part of the references are listed.
Article Infectious Diseases

COVID toes : Where do we stand with the current evidence?

Marie Baeck et al.

Summary: The relationship between chilblains and COVID-19 remains controversial, with some evidence suggesting an indirect association possibly due to lifestyle changes induced by lockdown.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Article Public, Environmental & Occupational Health

How and why patients made Long Covid

Felicity Callard et al.

Summary: Patients collectively created "Long Covid" and similar terms during the early months of the pandemic, demonstrating a longer and more complex illness course than initially reported. They used social media to spread their experiences and influence formal clinical and policy channels, showing how patients can contribute to changing the understanding and treatment of COVID-19.

SOCIAL SCIENCE & MEDICINE (2021)

Article Infectious Diseases

EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count

Stefania Paolucci et al.

Summary: This study monitored the immunologic profile and opportunistic viral DNA increase in Italian patients with COVID-19 to identify markers of disease severity. It found a correlation between reduced CD8(+) T cells and NK counts, elevated EBV DNA levels, and COVID-19 severity, highlighting the importance of further evaluating the relationship between EBV load and disease severity in longitudinal studies.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Article Medicine, General & Internal

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study (Publication with Expression of Concern. See vol. 401, pg. 90, 2023)

Chaolin Huang et al.

Summary: This study aimed to investigate the long-term health consequences of discharged COVID-19 patients and associated risk factors, particularly disease severity. Patients with more severe illness during hospitalization showed more severe impaired pulmonary diffusion capacities and abnormal chest imaging manifestations, highlighting the need for targeted interventions for long-term recovery.

LANCET (2021)

Review Immunology

Epstein-Barr Virus and Systemic Autoimmune Diseases

Gunnar Houen et al.

Summary: Epstein-Barr Virus (EBV) is a highly successful human herpes virus that infects essentially all humans at some point in their lives. EBV primarily spreads through saliva and can lead to infectious mononucleosis. The infection results in an immune response and production of antibodies, which can cause chronic relapsing/reactivating infections.

FRONTIERS IN IMMUNOLOGY (2021)

Review Chemistry, Medicinal

COVID-19-The Potential Beneficial Therapeutic Effects of Spironolactone during SARS-CoV-2 Infection

Katarzyna Kotfis et al.

Summary: Spironolactone has been shown to have potential benefits in preventing pulmonary fibrosis in COVID-19 infection, and its potassium-sparing diuretic action may also be beneficial in COVID-19 ARDS. As a well-known and widely used medication, spironolactone's pleiotropic effects could offer therapeutic benefits to patients with COVID-19 pneumonia.

PHARMACEUTICALS (2021)

Article Infectious Diseases

SARS-CoV-2 respiratory co-infections: Incidence of viral and bacterial co-pathogens

Vijay Singh et al.

Summary: This study investigated bacterial and viral co-infections in COVID-19 patients and found a lower rate of viral co-infections overall, but significant levels of Staphylococcus aureus and Epstein-Barr virus co-infections in SARS-CoV-2-positive patients. The findings contribute to our understanding of the current pandemic and can assist clinicians in making better patient care decisions.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Letter Medicine, General & Internal

Sequelae in Adults at 6 Months After COVID-19 Infection

Jennifer K. Logue et al.

JAMA NETWORK OPEN (2021)

Article Multidisciplinary Sciences

Positive Epstein-Barr virus detection in coronavirus disease 2019 (COVID-19) patients

Ting Chen et al.

Summary: This study revealed a high incidence of EBV coinfection in COVID-19 patients. Coinfection with EBV and SARS-CoV-2 was associated with fever and increased inflammation, indicating a potentially more severe condition.

SCIENTIFIC REPORTS (2021)

Article Infectious Diseases

High incidence of Epstein-Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19

A. Simonnet et al.

Summary: Critically ill patients with COVID-19 in the ICU are prone to herpesvirus reactivation, particularly with EBV, which occurs early and is associated with longer ICU stays.

INFECTIOUS DISEASES NOW (2021)

Article Otorhinolaryngology

New type of corona virus induced acute otitis media in adult

Vural Fidan

AMERICAN JOURNAL OF OTOLARYNGOLOGY (2020)

Article Medicine, General & Internal

Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019

Jerome R. Lechien et al.

JOURNAL OF INTERNAL MEDICINE (2020)

Article Cardiac & Cardiovascular Systems

Infarct-like myocarditis with coronary vasculitis and aneurysm formation caused by Epstein-Barr virus infection

Cristina Chimenti et al.

ESC HEART FAILURE (2020)

Article Critical Care Medicine

Clinical outcomes of COVID-19 in Wuhan, China: a large cohort study

Jiao Liu et al.

ANNALS OF INTENSIVE CARE (2020)

Editorial Material Medicine, General & Internal

Management of post-acute covid-19 in primary care

Trisha Greenhalgh et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Letter Critical Care Medicine

Correlation of interleukin-6 with Epstein-Barr virus levels in COVID-19

Georg Franz Lehner et al.

CRITICAL CARE (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Mediastinal Emphysema, Giant Bulla, and Pneumothorax Developed during the Course of COVID-19 Pneumonia

Ruihong Sun et al.

KOREAN JOURNAL OF RADIOLOGY (2020)

Review Oncology

Epstein-Barr virus strain variation and cancer

Teru Kanda et al.

CANCER SCIENCE (2019)

Letter Dermatology

May syphilis protect against human papillomavirus infection? An example of heterologous immunity

Francesco Drago et al.

GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA (2019)

Meeting Abstract Critical Care Medicine

EPSTEIN-BARR VIRUS-RELATED MULTISYSTEM FAILURE IN AN IMMUNOCOMPETENT YOUNG MAN

Bibi Aneesah Jaumally et al.

CRITICAL CARE MEDICINE (2018)

Article Multidisciplinary Sciences

Sequencing-based counting and size profiling of plasma Epstein-Barr virus DNA enhance population screening of nasopharyngeal carcinoma

W. K. Jacky Lam et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Virology

Epstein-Barr Virus Strains and Variations: Geographic or Disease-Specific Variants?

Marco Neves et al.

JOURNAL OF MEDICAL VIROLOGY (2017)

Article Medicine, General & Internal

Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal Cancer

K. C. Allen Chan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Multidisciplinary Sciences

Spironolactone blocks Epstein-Barr virus production by inhibiting EBV SM protein function

Dinesh Verma et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Review Oncology

Epstein-Barr virus: more than 50 years old and still providing surprises

Lawrence S. Young et al.

NATURE REVIEWS CANCER (2016)

Article Multidisciplinary Sciences

Seroprevalence of Epstein-Barr Virus Infection in US Children Ages 6-19, 2003-2010

Jennifer Beam Dowd et al.

PLOS ONE (2013)

Review Microbiology

Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections

Oludare A. Odumade et al.

CLINICAL MICROBIOLOGY REVIEWS (2011)

Article Endocrinology & Metabolism

Stress-induced reactivation of Epstein-Barr virus in astronauts

RP Stowe et al.

NEUROIMMUNOMODULATION (2000)